ARTICLE | Company News
SymbioTec, Xenetic Biosciences deal
January 23, 2012 8:00 AM UTC
Xenetic (formerly Lipoxen plc) completed its acquisition of cancer company SymbioTec. SymbioTec shareholders received 80 million Xenetic shares valued at £6.1 million ($9.3 million) based on Xenetic'...